ConvaTec Group Plc
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more
ConvaTec Group Plc (CNVVF) - Total Liabilities
Latest total liabilities as of June 2025: $1.96 Billion USD
Based on the latest financial reports, ConvaTec Group Plc (CNVVF) has total liabilities worth $1.96 Billion USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ConvaTec Group Plc - Total Liabilities Trend (2012–2024)
This chart illustrates how ConvaTec Group Plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ConvaTec Group Plc Competitors by Total Liabilities
The table below lists competitors of ConvaTec Group Plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Eurofins Scientific SE
PINK:ERFSF
|
USA | $7.40 Billion |
|
B2Gold Corp
NYSE MKT:BTG
|
USA | $2.23 Billion |
|
GXO Logistics Inc
NYSE:GXO
|
USA | $9.25 Billion |
|
Hexcel Corporation
NYSE:HXL
|
USA | $1.45 Billion |
|
Joby Aviation
NYSE:JOBY
|
USA | $469.86 Million |
|
Unigroup Guoxin Microelectronics Co Ltd
SHE:002049
|
China | CN¥4.93 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down ConvaTec Group Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.95 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ConvaTec Group Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ConvaTec Group Plc (2012–2024)
The table below shows the annual total liabilities of ConvaTec Group Plc from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.83 Billion | -9.64% |
| 2023-12-31 | $2.02 Billion | +1.95% |
| 2022-12-31 | $1.98 Billion | +0.16% |
| 2021-12-31 | $1.98 Billion | -5.56% |
| 2020-12-31 | $2.10 Billion | +2.29% |
| 2019-12-31 | $2.05 Billion | +0.27% |
| 2018-12-31 | $2.04 Billion | -10.27% |
| 2017-12-31 | $2.28 Billion | +0.41% |
| 2016-12-31 | $2.27 Billion | -43.45% |
| 2015-12-31 | $4.01 Billion | -3.48% |
| 2014-12-31 | $4.15 Billion | -6.40% |
| 2013-12-31 | $4.44 Billion | -30.12% |
| 2012-12-31 | $6.35 Billion | -- |